B
Bianca Weinstock-Guttman
Researcher at State University of New York System
Publications - 580
Citations - 29265
Bianca Weinstock-Guttman is an academic researcher from State University of New York System. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 83, co-authored 526 publications receiving 25870 citations. Previous affiliations of Bianca Weinstock-Guttman include Cleveland Clinic & Loma Linda University.
Papers
More filters
Journal ArticleDOI
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
Lawrence Jacobs,Diane Cookfair,Richard A. Rudick,Robert M. Herndon,John R. Richert,Andres M. Salazar,J. S. Fischer,Donald E. Goodkin,Carl V. Granger,Jack H. Simon,John J. Alam,David M. Bartoszak,Dennis Bourdette,Jonathan Braiman,Carol M. Brownscheidle,Michael E. Coats,Stanley Cohan,David S. Dougherty,R. P. Kinkel,Michele Mass,Frederick Munschauer,Roger L. Priore,Patrick M. Pullicino,Barbara J. Scherokman,Bianca Weinstock-Guttman,Ruth H. Whitham +25 more
TL;DR: Interferon beta‐ la had a significant beneficial impact in relapsing multiple sclerosis patients by reducing the accumulation of permanent physical disability, exacerbation frequency, and disease activity measured by gadolinium‐enhanced lesions on brain magnetic resonance images.
Journal ArticleDOI
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis
Richard A. Rudick,WH Stuart,Peter A. Calabresi,Christian Confavreux,Steven L. Galetta,Ernst Wilhelm Radue,Fred D. Lublin,Bianca Weinstock-Guttman,Daniel Wynn,F Lynn,Michael Panzara,Alfred Sandrock +11 more
TL;DR: Natalizumab added to interferon beta-1a was significantly more effective in patients with relapsing multiple sclerosis, and additional research is needed to elucidate the benefits and risks of this combination treatment.
Journal ArticleDOI
Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS)
Ralph H.B. Benedict,Diane Cookfair,Rebecca Gavett,Mark Gunther,Frederick Munschauer,Neeta Garg,Bianca Weinstock-Guttman +6 more
TL;DR: The purpose of this study was to examine the validity of the Minimal Assessment of Cognitive Function in MS (MACFIMS), a recommended battery based on the findings of an international conference held in 2001, and conclude that it is a valid approach to routine NP assessment of MS patients.
Journal ArticleDOI
Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change.
Ralph H.B. Benedict,Elizabeth L. Wahlig,Rohit Bakshi,Inna Fishman,Frederick Munschauer,Robert Zivadinov,Bianca Weinstock-Guttman +6 more
TL;DR: It is concluded that self-report HQOL indices are most strongly predicted by measures of depression, whereas vocational status is predicted primarily by objective measures of cognitive function.
Journal ArticleDOI
Thalamic atrophy and cognition in multiple sclerosis
Maria K. Houtchens,Ralph H.B. Benedict,Ronald J. Killiany,Jitendra Sharma,Zeenat Jaisani,Baljinder Singh,Bianca Weinstock-Guttman,Charles R.G. Guttmann,Rohit Bakshi +8 more
TL;DR: Thalamic atrophy is a clinically relevant biomarker of the neurodegenerative disease process in multiple sclerosis, suggesting clinical relevance of damage to surrounding structures, such as the thalamus.